The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology

SIMPLE SUMMARY: The programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) pathway inhibits the function of activated immune cells. This mediates immune tolerance and prevents immune-mediated tissue destruction. The malfunction of this pathway is involved in the pathogenesis of chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöniger, Sandra, Jasani, Bharat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558501/
https://www.ncbi.nlm.nih.gov/pubmed/36230402
http://dx.doi.org/10.3390/ani12192661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558501/
https://www.ncbi.nlm.nih.gov/pubmed/36230402
http://dx.doi.org/10.3390/ani12192661

Ejemplares similares